IRIDEX Investor Relations Material
Latest events
Q2 2025
IRIDEX
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IRIDEX Corp
Access all reports
IRIDEX Corp is a medical technology company specializing in the development and commercialization of innovative laser-based systems for the treatment of eye diseases. The company’s products are primarily used in ophthalmology for the treatment of glaucoma, retinal diseases, and other vision-threatening conditions. IRIDEX’s laser systems and related consumables are designed to provide precise and minimally invasive treatment options for patients, improving outcomes and reducing recovery times. The company is headquartered in Mountain View, California, USA, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
IRIX
Country
🇺🇸 United States